About ElanElan Corporation.

About ElanElan Corporation, plc is a neuroscience – based biotechnology company. We are a difference a difference in the lives of patients and their families through the provision of us, scientific innovations for unmet medical needs, that can be found all over the world before. Elan shares trade on the New York, London and Dublin listed. For more information about the company, please visit the Safe Harbor / Forward-Looking Statements.

AFFIRM is a two-year, randomized, multicentre, placebo-controlled, double-blind study of 942 patients in 99 sites performed worldwide the impact the impact of TYSABRI on the progression of disability by the Expanded Disability Status Scale. and the rate of clinical relapses, the patients were randomized to receive either a 300 mg iV infusion dose of TYSABRI or placebo received all four weeks. Continue reading

Or six years.

According to Piot, the country has made progress in improving access to antiretroviral drugs, and the government and society are increasingly willing to confront China’s HIV / AIDS situation. I have come to China for 14 to 15 years, and I can say that was the first five or six years, it’s basically no receptivity, Piot said, adding:. Well, today a lot is going on in systems are being. Way I think it’s really different, There is also strong leadership in China, said Piot added, . Education is it’s money, I think key obstacles are the size of the country and everyone needs to know on the subject..

Deputy Minister of Health Wang Longde which increase as the country HIV / AIDS chief, said on Tuesday that China this year spend on 960 million yuan, or about $ 127 million to antiretroviral drugs, and HIV plans educational work. The government also plans to reach out to sex with men sex with men , said Wang (Blanchard, Reuters. Continue reading

SOURCES: Richard A.

Associate Chair, Environment and Safety Sciences, School of Public Health, miscarriages Seattle; Deborah Cory – Slechta, Professor, Environmental Medicine, University of Rochester Medical Center, Keith A. Vice Chairman, Research, Texas A & M Health Science Center College of Medicine, Department of Psychiatry and Behavioral Sciences, neuroimaging and genetics core return return VA Center of Excellence for Research on war Veterans at the Central Texas veterans Health Care System, July 2009, Institute of Medicine report to accumulate more differences, and diagnoses get more sure and valid, he said.

Recovery, may trigger drug addictiondevelops Eleven patients with Parkinson’s disease pathological gambling to dopamine agonist therapy, a drug therapy to control movement problems to control caused by Parkinson’s disease, according to, a study published online today that will appear in the September print issue of the Archives of Neurology, one of the JAMA / Archives journals. Continue reading

Cardiovascular drugs?

Pashkow also said that could be the work of Mason ‘s lab suggests astaxanthin for the discovery for the discovery an entirely new class of safe, cardiovascular drugs? ‘This potent antioxidant may be the third great wave of modern therapy for secondary prevention of heart attack and stroke. The heart to work these funds likely by reprogramming the cellular oxidation balance to the cell and tissue cultures inflammatory response to blunt injury and damage to the border myocardium. ‘.

In addition, by limiting the amount of oxidative damage to LDL, the bad cholesterol , an astaxanthin could alter the progression of atherosclerosis clogged, the underlying inflammation that arteries and is responsible for most heart attacks and strokes when an atherosclerotic. Cardax Pharmaceuticals is exploring the use of astaxanthin and novel derivatives of astaxanthin and other carotenoids for use as medical agents in disease states characterized by abnormal cellular oxidation and chronic inflammation . Continue reading